82 related items for PubMed ID: 1413984
1. Influence of supplementation with N-3 fatty acids on different coronary risk factors in men--a placebo controlled study.
Deslypere JP.
Verh K Acad Geneeskd Belg; 1992; 54(3):189-216. PubMed ID: 1413984
[Abstract] [Full Text] [Related]
2. Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease.
Berrettini M, Parise P, Ricotta S, Iorio A, Peirone C, Nenci GG.
Thromb Haemost; 1996 Mar; 75(3):395-400. PubMed ID: 8701396
[Abstract] [Full Text] [Related]
3. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG, Jitomir J, Wilson RL, Gentile M.
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[Abstract] [Full Text] [Related]
4. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M, Schmidt EB, Jørgensen KA, Christensen JH.
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[Abstract] [Full Text] [Related]
5. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.
Dyerberg J, Eskesen DC, Andersen PW, Astrup A, Buemann B, Christensen JH, Clausen P, Rasmussen BF, Schmidt EB, Tholstrup T, Toft E, Toubro S, Stender S.
Eur J Clin Nutr; 2004 Jul; 58(7):1062-70. PubMed ID: 15220949
[Abstract] [Full Text] [Related]
6. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L.
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[Abstract] [Full Text] [Related]
7. Polyunsaturated fatty acids of the n-6 and n-3 series: effects on postprandial lipid and apolipoprotein levels in healthy men.
Zampelas A, Peel AS, Gould BJ, Wright J, Williams CM.
Eur J Clin Nutr; 1994 Dec; 48(12):842-8. PubMed ID: 7889892
[Abstract] [Full Text] [Related]
8. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
Galan P, de Bree A, Mennen L, Potier de Courcy G, Preziozi P, Bertrais S, Castetbon K, Hercberg S.
J Nutr Health Aging; 2003 Dec; 7(6):428-35. PubMed ID: 14625623
[Abstract] [Full Text] [Related]
9. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
Berstad P, Seljeflot I, Veierød MB, Hjerkinn EM, Arnesen H, Pedersen JI.
Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702
[Abstract] [Full Text] [Related]
10. n -- 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids.
Barden AE, Dunstan JA, Beilin LJ, Prescott SL, Mori TA.
Clin Sci (Lond); 2006 Oct; 111(4):289-94. PubMed ID: 16822237
[Abstract] [Full Text] [Related]
11. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE.
Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
[Abstract] [Full Text] [Related]
12. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
Bukowska H.
Ann Acad Med Stetin; 1998 May; 44():29-43. PubMed ID: 9857530
[Abstract] [Full Text] [Related]
13. Influence of n-3 polyunsaturated fatty acids on soluble cellular adhesion molecules as biomarkers of cardiovascular risk in young healthy subjects.
Paulo MC, Andrade AM, Andrade ML, Morais MG, Kiely M, Parra D, Martinéz JA, Thorsdottir I, Bandarra NM.
Nutr Metab Cardiovasc Dis; 2008 Dec; 18(10):664-70. PubMed ID: 18420395
[Abstract] [Full Text] [Related]
14. Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia.
Nordøy A, Hansen JB, Brox J, Svensson B.
Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):7-16. PubMed ID: 11383326
[Abstract] [Full Text] [Related]
15. Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals.
Nenseter MS, Østerud B, Larsen T, Strøm E, Bergei C, Hewitt S, Holven KB, Hagve TA, Mjøs SA, Solvang M, Pettersen J, Opstvedt J, Ose L.
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):323-30. PubMed ID: 11302007
[Abstract] [Full Text] [Related]
16. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
Bairati I, Roy L, Meyer F.
Can J Cardiol; 1992 Dec; 8(1):41-6. PubMed ID: 1617510
[Abstract] [Full Text] [Related]
17. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
Lungershausen YK, Abbey M, Nestel PJ, Howe PR.
J Hypertens; 1994 Sep; 12(9):1041-5. PubMed ID: 7852747
[Abstract] [Full Text] [Related]
18. [Effect of fish oils on plasma lipid risk factors and esterified fatty acids in primary hyperlipoproteinemia].
Zák A, Zeman M, Tvrzická E.
Sb Lek; 1997 Sep; 98(3):213-24. PubMed ID: 9601814
[Abstract] [Full Text] [Related]
19. Influence of a concentrated ethylester compound of n-3 fatty acids on lipids, platelets and coagulation in patients undergoing coronary bypass surgery.
Nilsen DW, Dalaker K, Nordøy A, Osterud B, Ingebretsen OC, Lyngmo V, Almdahl S, Vaage J, Rasmussen K.
Thromb Haemost; 1991 Aug 01; 66(2):195-201. PubMed ID: 1771612
[Abstract] [Full Text] [Related]
20. Fish oil as an adjuvant in the treatment of hypertension.
Gray DR, Gozzip CG, Eastham JH, Kashyap ML.
Pharmacotherapy; 1996 Aug 01; 16(2):295-300. PubMed ID: 8820475
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
